Cargando…
Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease
Interferon (IFN)-β is a popular therapy for multiple sclerosis (MS). However, 25–40% of patients are nonresponsive to this therapy, and it worsens neuromyelitis optica (NMO), another neuroinflammatory disease. We previously identified, in both NMO patients and in mice, that IFN-β treatment had infla...
Autores principales: | Agasing, Agnieshka, Quinn, James L., Kumar, Gaurav, Axtell, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392231/ https://www.ncbi.nlm.nih.gov/pubmed/34440908 http://dx.doi.org/10.3390/cells10082139 |
Ejemplares similares
-
Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation
por: Quinn, James L., et al.
Publicado: (2018) -
Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE
por: Maria, Zahra, et al.
Publicado: (2021) -
Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica
por: Agasing, Agnieshka M., et al.
Publicado: (2020) -
CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS
por: Kumar, Gaurav, et al.
Publicado: (2021) -
Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis
por: Larabee, Chelsea M., et al.
Publicado: (2016)